The influence of synaptic activity on neuronal health

Current Opinion in Neurobiology

Volumn 21, Issue 2, 2011, Pages 299-305

  Bell, Karen FS ^a   Hardingham, Giles E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 9; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBROBLAST GROWTH FACTOR 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PUMA PROTEIN; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NFAT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; CALCIUM TRANSPORT; DEGENERATIVE DISEASE; ENZYME REGULATION; EXCITOTOXICITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUNTINGTON CHOREA; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPINAL MUSCULAR ATROPHY; SYNAPTIC POTENTIAL; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 79955654901     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2011.01.002     Document Type: Review

References (65)

1. Isacson O. On neuronal health. Trends Neurosci 1993, 16:306-308.
2. Mennerick S., Zorumski C.F. Neural activity and survival in the developing nervous system. Mol Neurobiol 2000, 22:41-54.
3. Corredor R.G., Goldberg J.L. Electrical activity enhances neuronal survival and regeneration. J Neural Eng 2009, 6:055001.
4. Bessero A.C., Clarke P.G. Neuroprotection for optic nerve disorders. Curr Opin Neurol 2010, 23:10-15.
5. Tauskela J.S., Fang H., Hewitt M., Brunette E., Ahuja T., Thivierge J.P., Comas T., Mealing G.A. Elevated synaptic activity preconditions neurons against an in vitro model of ischemia. J Biol Chem 2008, 283:34667-34676.
6. Papadia S., Soriano F.X., Leveille F., Martel M.A., Dakin K.A., Hansen H.H., Kaindl A., Sifringer M., Fowler J., Stefovska V., et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 2008, 11:476-487.
7. Fishbein I., Segal M. Active cortical innervation protects striatal neurons from slow degeneration in culture. J Neural Transm 2010.
8. Olney J.W., Wozniak D.F., Jevtovic-Todorovic V., Barber N., Bittigau P., Ikonomidou C. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol 2002, 12:488-498.
9. Hardingham G.E. Pro-survival signalling from the NMDA receptor. Biochem Soc Trans 2006, 34:936-938.
10. Ikonomidou C., Stefovska V., Turski L. Neuronal death enhanced by N-methyl-d-aspartate antagonists. Proc Natl Acad Sci USA 2000, 97:12885-12890.
11. Tashiro A., Sandler V.M., Toni N., Zhao C., Gage F.H. NMDA-receptor-mediated, cell-specific integration of new neurons in adult dentate gyrus. Nature 2006, 442:929-933.
12. Hardingham G.E., Fukunaga Y., Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002, 5:405-414.
13. Hardingham G.E. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans 2009, 37:1147-1160.
14. Hardingham G.E., Arnold F.J., Bading H. Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat Neurosci 2001, 4:261-267.
15. Saha R.N., Dudek S.M. Action potentials: to the nucleus and beyond. Exp Biol Med (Maywood) 2008, 233:385-393.
16. Lee B., Butcher G.Q., Hoyt K.R., Impey S., Obrietan K. Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133. J Neurosci 2005, 25:1137-1148.
17. Papadia S., Stevenson P., Hardingham N.R., Bading H., Hardingham G.E. Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J Neurosci 2005, 25:4279-4287.
18. Soriano F.X., Hardingham G.E. Compartmentalized NMDA receptor signalling to survival and death. J Physiol 2007, 584:381-387.
19. Zhang S.J., Zou M., Lu L., Lau D., Ditzel D.A., Delucinge-Vivier C., Aso Y., Descombes P., Bading H. Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity. PLoS Genet 2009, 5:e1000604.
20. Vashishta A., Habas A., Pruunsild P., Zheng J.J., Timmusk T., Hetman M. Nuclear factor of activated T-cells isoform c4 (NFATc4/NFAT3) as a mediator of antiapoptotic transcription in NMDA receptor-stimulated cortical neurons. J Neurosci 2009, 29:15331-15340.
21. Zheng S., Eacker S.M., Hong S.J., Gronostajski R.M., Dawson T.M., Dawson V.L. NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice. J Clin Invest 2010, 120:2446-2456.
22. Ciavatta V.T., Kim M., Wong P., Nickerson J.M., Shuler R.K., McLean G.Y., Pardue M.T. Retinal expression of Fgf2 in RCS rats with subretinal microphotodiode array. Invest Ophthalmol Vis Sci 2009, 50:4523-4530.
23. Morimoto T., Fujikado T., Choi J.S., Kanda H., Miyoshi T., Fukuda Y., Tano Y. Transcorneal electrical stimulation promotes the survival of photoreceptors and preserves retinal function in royal college of surgeons rats. Invest Ophthalmol Vis Sci 2007, 48:4725-4732.
24. Soriano F.X., Papadia S., Hofmann F., Hardingham N.R., Bading H., Hardingham G.E. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci 2006, 26:4509-4518.
25. Lipsky R.H., Marini A.M. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann N Y Acad Sci 2007, 1122:130-143.
26. Angelucci F., De Bartolo P., Gelfo F., Foti F., Cutuli D., Bossu P., Caltagirone C., Petrosini L. Increased concentrations of nerve growth factor and brain-derived neurotrophic factor in the rat cerebellum after exposure to environmental enrichment. Cerebellum 2009, 8:499-506.
27. Bruno M.A., Cuello A.C. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci USA 2006, 103:6735-6740.
28. Nishijima T., Piriz J., Duflot S., Fernandez A.M., Gaitan G., Gomez-Pinedo U., Verdugo J.M., Leroy F., Soya H., Nunez A., et al. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 2010, 67:834-846.
29. Lau D., Bading H. Synaptic activity-mediated suppression of p53 and induction of nuclear calcium-regulated neuroprotective genes promote survival through inhibition of mitochondrial permeability transition. J Neurosci 2009, 29:4420-4429.
30. Leveille F., Papadia S., Fricker M., Bell K.F., Soriano F.X., Martel M.A., Puddifoot C., Habel M., Wyllie D.J., Ikonomidou C., et al. Suppression of the intrinsic apoptosis pathway by synaptic activity. J Neurosci 2010, 30:2623-2635.
31. Al-Mubarak B., Soriano F.X., Hardingham G.E. Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene. Channels (Austin) 2009, 3:233-238.
32. Dick O., Bading H. Synaptic activity and nuclear calcium signaling protect hippocampal neurons from death signal-associated nuclear translocation of FoxO3a induced by extrasynaptic N-methyl-d-aspartate receptors. J Biol Chem 2010, 285:19354-19361.
33. Hedskog L., Petersen C.A., Svensson A.I., Welander H., Tjernberg L.O., Karlstrom H., Ankarcrona M. Gamma-secretase complexes containing caspase-cleaved presenilin-1 increase intracellular Abeta42/Abeta40 ratio. J Cell Mol Med 2010, [Epub ahead of print]. 10.1111/j.1582-4934.2010.01208.x.
34. Nikolaev A., McLaughlin T., O'Leary D.D., Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457:981-989.
35. de Calignon A., Fox L.M., Pitstick R., Carlson G.A., Bacskai B.J., Spires-Jones T.L., Hyman B.T. Caspase activation precedes and leads to tangles. Nature 2010, 464:1201-1204.
36. D'Amelio M., Cavallucci V., Middei S., Marchetti C., Pacioni S., Ferri A., Diamantini A., De Zio D., Carrara P., Battistini L., et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 2010, 14:69-76.
37. Li Z., Jo J., Jia J.M., Lo S.C., Whitcomb D.J., Jiao S., Cho K., Sheng M. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 2010, 141:859-871.
38. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., Handschin C., Zheng K., Lin J., Yang W., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
39. Soriano F.X., Leveille F., Papadia S., Bell K.F., Puddifoot C., Hardingham G.E. Neuronal activity controls the antagonistic balance between PGC-1alpha and SMRT in regulating antioxidant defences. Antioxid Redox Signal 2010.
40. Mckenzie G.J., Stephenson P., Ward G., Papadia S., Bading H., Chawla S., Privalsky M., Hardingham G.E. Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. J Neurochem 2005, 93:171-185.
41. MacAskill A.F., Kittler J.T. Control of mitochondrial transport and localization in neurons. Trends Cell Biol 2010, 20:102-112.
42. Li Z., Okamoto K., Hayashi Y., Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119:873-887.
43. Rintoul G.L., Filiano A.J., Brocard J.B., Kress G.J., Reynolds I.J. Glutamate decreases mitochondrial size and movement in primary forebrain neurons. J Neurosci 2003, 23:7881-7888.
44. Chang D.T., Honick A.S., Reynolds I.J. Mitochondrial trafficking to synapses in cultured primary cortical neurons. J Neurosci 2006, 26:7035-7045.
45. Wang X., Schwarz T.L. The mechanism of Ca2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell 2009, 136:163-174.
46. Mironov S.L. ADP regulates movements of mitochondria in neurons. Biophys J 2007, 92:2944-2952.
47. Saotome M., Safiulina D., Szabadkai G., Das S., Fransson A., Aspenstrom P., Rizzuto R., Hajnoczky G. Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci USA 2008, 105:20728-20733.
48. Macaskill A.F., Rinholm J.E., Twelvetrees A.E., Arancibia-Carcamo I.L., Muir J., Fransson A., Aspenstrom P., Attwell D., Kittler J.T. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 2009, 61:541-555.
49. Sung J.Y., Engmann O., Teylan M.A., Nairn A.C., Greengard P., Kim Y. WAVE1 controls neuronal activity-induced mitochondrial distribution in dendritic spines. Proc Natl Acad Sci USA 2008, 105:3112-3116.
50. Wareski P., Vaarmann A., Choubey V., Safiulina D., Liiv J., Kuum M., Kaasik A. PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons. J Biol Chem 2009, 284:21379-21385.
51. Marcello E., Gardoni F., Mauceri D., Romorini S., Jeromin A., Epis R., Borroni B., Cattabeni F., Sala C., Padovani A., et al. Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci 2007, 27:1682-1691.
52. Hoey S.E., Williams R.J., Perkinton M.S. Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J Neurosci 2009, 29:4442-4460.
53. Bordji K., Becerril-Ortega J., Nicole O., Buisson A. Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-{beta} production. J Neurosci 2010, 30:15927-15942.
54. Tampellini D., Rahman N., Gallo E.F., Huang Z., Dumont M., Capetillo-Zarate E., Ma T., Zheng R., Lu B., Nanus D.M., et al. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci 2009, 29:9704-9713.
55. Tampellini D., Capetillo-Zarate E., Dumont M., Huang Z., Yu F., Lin M.T., Gouras G.K. Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. J Neurosci 2010, 30:14299-14304.
56. Kong Y., Ruan L., Qian L., Liu X., Le Y. Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme. J Neurosci 2010, 30:11848-11857.
57. Biondi O., Grondard C., Lecolle S., Deforges S., Pariset C., Lopes P., Cifuentes-Diaz C., Li H., della Gaspera B., Chanoine C., et al. Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 2008, 28:953-962.
58. Biondi O., Branchu J., Sanchez G., Lancelin C., Deforges S., Lopes P., Pariset C., Lecolle S., Cote J., Chanoine C., et al. In vivo NMDA receptor activation accelerates motor unit maturation, protects spinal motor neurons, and enhances SMN2 gene expression in severe spinal muscular atrophy mice. J Neurosci 2010, 30:11288-11299.
59. Spalloni A., Origlia N., Sgobio C., Trabalza A., Nutini M., Berretta N., Bernardi G., Domenici L., Ammassari-Teule M., Longone P. Postsynaptic alteration of NR2A subunit and defective autophosphorylation of alphaCaMKII at threonine-286 contribute to abnormal plasticity and morphology of upper motor neurons in presymptomatic SOD1G93A mice, a murine model for amyotrophic lateral sclerosis. Cereb Cortex 2010.
60. Okamoto S., Pouladi M.A., Talantova M., Yao D., Xia P., Ehrnhoefer D.E., Zaidi R., Clemente A., Kaul M., Graham R.K., et al. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med 2009, 15:1407-1413.
61. Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006, 127:59-69.
62. Lin J., Wu P.H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.Y., Mootha V.K., Jager S., Vianna C.R., Reznick R.M., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004, 119:121-135.
63. Weydt P., Pineda V.V., Torrence A.E., Libby R.T., Satterfield T.F., Lazarowski E.R., Gilbert M.L., Morton G.J., Bammler T.K., Strand A.D., et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab 2006, 4:349-362.
64. Milnerwood A.J., Gladding C.M., Pouladi M.A., Kaufman A.M., Hines R.M., Boyd J.D., Ko R.W., Vasuta O.C., Graham R.K., Hayden M.R., et al. Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron 2010, 65:178-190.
65. Xia P., Chen H.S., Zhang D., Lipton S.A. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci 2010, 30:11246-11250.